Predicting Future Heart Failure in Survivors of Childhood Cancer by Kocarnik, Jonathan
November 17, 2014 SCIENCE SPOTLIGHT 
 
1 Volume 4, Number 11 | Fred Hutchinson Cancer Research Center 
 
Predicting Future Heart Failure in Survivors of 
Childhood Cancer 
November 17, 2014 
    JM Kocarnik 
There are more than 400,000 childhood cancer survivors living in the United States 
today.  Cardiovascular disease is one of the main contributors to morbidity and mortality in this 
population, as survivors are at a significantly increased risk of cardiomyopathy leading to congestive 
heart failure (CHF).  Risk scores which predict individual risk of future cardiovascular disease could 
help identify those at highest risk, and steer those individuals towards earlier screening and 
treatment.  While such scores have been created for older adults, they have not been developed for 
this high-risk group.  In a recent report in the Journal of Clinical Oncology, Drs. Eric Chow and 
Norman Breslow in the Public Health Sciences and Clinical Research Divisions developed a model 
that can predict the risk of subsequent heart failure among childhood cancer survivors. 
To build these risk models, the authors utilized data from the Childhood Cancer Survivor Study, 
which follows childhood cancer survivors over time to identify any long term outcomes that might 
result from their cancer or treatment history.  For this study they observed over 13,000 survivors 
through the age of 40 years for the development of heart failure, defined as heart failure leading to 
death or requiring medications or heart transplantation.  4,000 siblings of the cancer survivors were 
also followed over time, which helped establish the baseline population risk of heart failure for 
comparison.  "We took readily available clinical information such as age, sex, and exposure to 
radiation and certain chemotherapy agents that one should have recorded as elements of a standard 
cancer survivor treatment summary/care plan," said lead author Dr. Chow.  Together, this data 
provided a rich resource for building a risk prediction model from historical records.  
The authors developed their risk score by evaluating the relationship between CHF and various 
selected exposures.  Age at diagnosis, sex, chemotherapy (anthracycline), and radiotherapy were 
significantly associated with CHF.  Regression estimates from these variables were converted into 
integer values that could then be added together and assigned to low, moderate, high, and very high 
risk group categories.  These risk groups separated individuals into groups with substantially 
different risks of CHF by age 40 (see figure).  For the group predicted at low risk, the cumulative 
incidence of CHF was not significantly elevated compared to that of the siblings (0.5 vs. 0.3 percent 
by age 40), while the cumulative incidence of CHF was considerably higher for the "very high" risk 
group (greater than 20 percent by age 40).  
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The risk model showed good performance when applied to the Childhood Cancer Survivor Study 
data, with an area under the curve of 0.74, and was then tested in other studies to validate its 
performance.  "Obtaining the collaboration of multiple investigators from other large childhood 
cancer survivor cohorts was critical in helping us validate our prediction models," said Dr. 
Chow.  "These included other investigators from the Hutch (i.e. Norm Breslow of the National Wilms 
Tumor Study), and those from St. Jude Children’s Research Hospital and from the 
Netherlands."  The risk models showed generally similar prediction ability in these independent 
validation studies (areas under the curve of 0.68 to 0.82), demonstrating the broader applicability of 
the model. 
To make the risk score easily accessible, the authors created a website form (link below) that easily 
calculates an individual risk.  This form requires entering only a few pieces of information, each of 
which should be readily available to clinicians soon after completion of childhood cancer 
therapy.  This risk assessment can then be utilized for personalizing future screening strategies and 
interventions.  Such an assessment could be useful not only for pinpointing those at high risk who 
may benefit from earlier detection and intervention, but also for identifying those at low risk who 
might only require standard surveillance. 
Moving forward, the authors are working to make the model even more robust.  "While the paper’s 
risk score of around 0.75 is reasonably good, it can still be improved," explains Dr. Chow.  "We are 
more deeply examining the influence and utility of incorporating conventional risk factors such as 
hypertension, dyslipidemia, and diabetes into the model. We are also developing similar models to 
predict risk of ischemic heart disease and stroke after childhood cancer as well." 
Link to online risk calculator: ccss.stjude.org/chfcalc 
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Image provided by Dr. Eric Chow 
Cumulative incidence of congestive heart failure among 
childhood cancer survivors, grouped by a risk score accounting 
for sex, age at cancer diagnosis, chemotherapy (anthracycline) 
dose, and chest radiotherapy dose. 
 
